logo

MEI Pharma Secures Over $100 Million Funding Commitment to Launch Litecoin Treasury Strategy

By: theblockbeats.news|2025/07/18 16:42:12

BlockBeats News, July 19th, Titan Partners Group and crypto investment firm GSR are co-leading a strategic transformation of the US pharmaceutical company MEI Pharma (NASDAQ: MEIP), driving the establishment of a dedicated Litecoin treasury strategy. Currently, there has been over $100 million in funding commitments to this project.


It is worth mentioning that Litecoin creator Charlie Lee has agreed to join the MEI Pharma board of directors. Furthermore, the Litecoin Foundation has also invested in MEI Pharma as the company's treasury strategy aligns closely with the Litecoin Foundation's core mission of promoting global Litecoin adoption.

Bitget vs. Binance vs. WEEX биржа: Сравнительный анализ CEX и потенциал токенов 2025
Прогноз Цены yearn.finance(YFI) Coin: Рост на 15% к Апрелю 2025 – Достигнет ли $6000?

Вам также может понравиться

Поделиться
copy

Растущие активы

Последние новости криптовалют

03:48

Coinbase to Include HBAR, MANTLE in COIN50 Index for Q4

03:18

In an Anthropic simulation test, AI Agents discovered a $4.6 million smart contract vulnerability.

23:52

Fed Future Meetings Risk Seeing Increased Disagreements Fueling Market Volatility

23:50

Tom Lee: Соотношение риска и вознаграждения BTC и ETH становится довольно привлекательным

23:47

Coinbase теперь в прямом эфире со спотовой торговлей Rayls (RLS)

Еще
Сообщество
icon
icon
icon
icon
icon
icon
icon
icon
icon
icon

Служба поддержки@weikecs

Деловое сотрудничество@weikecs

Количественная торговля и ММ[email protected]

VIP-программа[email protected]